npj Parkinson's Disease (Mar 2024)

Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease

  • Diana L. Price,
  • Asma Khan,
  • Rachel Angers,
  • Alvaro Cardenas,
  • Maria Key Prato,
  • Massimo Bani,
  • Douglas W. Bonhaus,
  • Martin Citron,
  • Anja-Leona Biere

DOI
https://doi.org/10.1038/s41531-024-00658-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 2

Abstract

Read online

No abstracts available.